SCHEMBL7124202

SCHEMBL7124202

CC(C)(C)OC(=O)Nc1ccc2nc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)sc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.54
MAPT P10636 6/20 0.54
RAB9A P51151 4/20 0.54
NPC1 O15118 2/20 0.54
CACNA1B Q00975 1/20 0.54
APBA1 Q02410 1/20 0.54
KMT2A Q03164 5/20 0.53
MEN1 O00255 4/20 0.53
ALDH1A1 P00352 4/20 0.53
MCL1 Q07820 2/20 0.53
HPGD P15428 1/20 0.53
HTT P42858 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MMP13 P45452 1/20 0.52
LMNA P02545 3/20 0.51
CXCR2 P25025 1/20 0.51
POLB P06746 1/20 0.51
THRB P10828 1/20 0.51
SCD O00767 1/20 0.49
LCK P06239 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7123602 0.88 DYRK1A (0.67) DYRK1AMAPTRAB9ANPC1CACNA1B
SCHEMBL7125923 0.85 DYRK1A (0.57) DYRK1AMAPTRAB9ANPC1CACNA1B
SCHEMBL7129461 0.85 DYRK1A (0.70) DYRK1AMAPTRAB9ANPC1CACNA1B
SCHEMBL7125975 0.83 MAPT (0.62) DYRK1AMAPTRAB9ANPC1CACNA1B
SCHEMBL30493298 0.83 DYRK1A (0.70) DYRK1AMAPTRAB9ANPC1CACNA1B
SCHEMBL3949427 0.83 DYRK1A (0.70) DYRK1AMAPTRAB9ANPC1CACNA1B
SCHEMBL7162058 0.82 DYRK1A (0.64) DYRK1AMAPTRAB9ANPC1CACNA1B
SCHEMBL7127487 0.82 MMP13 (0.74) DYRK1AMAPTRAB9ANPC1CACNA1B
SCHEMBL7127519 0.82 SCD (0.73) DYRK1AMAPTRAB9ANPC1CACNA1B
SCHEMBL7124297 0.81 DYRK1A (0.61) DYRK1AMAPTRAB9ANPC1CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US claimed
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD DYRK1A 3783/4885MAPT 4391/4885RAB9A 1179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.